Novel Infected Tissue Model for Pre-Clinical Evaluation of Antimicrobial Compounds
NovaBay PharmaceuticalsIn a recent study presented at this year’s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), a team led by Dr. Dmitri Debabov, head of Cell and Microbiology, and Meghan Zuck, a Research Associate, at NovaBay Pharmaceuticals, reported the development of infected tissue models for its Aganocide® compounds.